Nebido (undecanoate) and the reconstitution argument. Half the threads on this are arguing past each other about arithmetic.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
If you need three other compounds to notice the first one, you have not tested the first one.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Where does the human data stop and the extrapolation begin? That is the whole thread. Eight months in on undecanoate and it lines up.
This board overrates bloodwork. A number moving is not the outcome you wanted.
Read methods. Raised haematocrit was my main issue with undecanoate too.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Most of what is called evidence here is one person, one vial, one month. How long have you been on undecanoate?
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all?
Most of what is called evidence here is one person, one vial, one month.
Same here.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Narrow conclusion.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Test one thing at a time. It feels slower and it is the only way to learn anything.